Business Description
Caribou Biosciences Inc
NAICS : 541713
SIC : 2833
ISIN : US1420381089
Share Class Description:
CRBU: Ordinary SharesDescription
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.57 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -0.61 | |||||
| Beneish M-Score | -3.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.5 | |||||
| 3-Year EBITDA Growth Rate | -6.2 | |||||
| 3-Year EPS without NRI Growth Rate | -4.3 | |||||
| 3-Year FCF Growth Rate | -4.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -16.16 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.95 | |||||
| 9-Day RSI | 56.35 | |||||
| 14-Day RSI | 53.78 | |||||
| 6-1 Month Momentum % | -40.4 | |||||
| 12-1 Month Momentum % | -69.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.38 | |||||
| Quick Ratio | 7.38 | |||||
| Cash Ratio | 7.1 | |||||
| Days Sales Outstanding | 16.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -47.3 | |||||
| Shareholder Yield % | -6.33 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1439.5 | |||||
| Net Margin % | -1290.81 | |||||
| FCF Margin % | -1153.58 | |||||
| ROE % | -43.52 | |||||
| ROA % | -36.78 | |||||
| ROIC % | -144.26 | |||||
| ROC (Joel Greenblatt) % | -409.63 | |||||
| ROCE % | -44.19 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 17.31 | |||||
| PB Ratio | 0.71 | |||||
| Price-to-Tangible-Book | 0.71 | |||||
| EV-to-EBIT | 0.11 | |||||
| EV-to-EBITDA | 0.12 | |||||
| EV-to-Revenue | -1.62 | |||||
| EV-to-Forward-Revenue | 1.08 | |||||
| EV-to-FCF | 0.14 | |||||
| Price-to-Net-Current-Asset-Value | 1.15 | |||||
| Price-to-Net-Cash | 1.21 | |||||
| Earnings Yield (Greenblatt) % | 909.09 | |||||
| FCF Yield % | -66.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CRBU
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Caribou Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 11.475 | ||
| EPS (TTM) ($) | -1.66 | ||
| Beta | 2.27 | ||
| Volatility % | 109.16 | ||
| 14-Day RSI | 53.78 | ||
| 14-Day ATR ($) | 0.216977 | ||
| 20-Day SMA ($) | 2.24325 | ||
| 12-1 Month Momentum % | -69.22 | ||
| 52-Week Range ($) | 1.5 - 8.33 | ||
| Shares Outstanding (Mil) | 90.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Caribou Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Caribou Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Caribou Biosciences Inc Frequently Asked Questions
What is Caribou Biosciences Inc(CRBU)'s stock price today?
The current price of CRBU is $2.20. The 52 week high of CRBU is $8.33 and 52 week low is $1.50.
When is next earnings date of Caribou Biosciences Inc(CRBU)?
The next earnings date of Caribou Biosciences Inc(CRBU) is 2025-03-11 Est..
Does Caribou Biosciences Inc(CRBU) pay dividends? If so, how much?
Caribou Biosciences Inc(CRBU) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers